부산대학교 도서관

Eisenberg DM; Harris ES; Littlefield BA; Cao S; Craycroft JA; Scholten R; Bayliss P; Fu Y; Wang W; Qiao Y; Zhao Z; Chen H; Liu Y; Kaptchuk T; Hahn WC; Wang X; Roberts T; Shamu CE; Clardy J

Fitoterapia. Jan2011, Vol. 82 Issue 1, p17-33. 17p.

Craycroft JA; Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY, USA.; Huang J; Department of Anesthesiology & Perioperative Medicine, University of Louisville, Louisville, KY, USA.; Kong M; Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY, USA.

Publisher: SAGE Publications Country of Publication: England NLM ID: 9212457 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0334 (Electronic) Linking ISSN: 09622802 NLM ISO Abbreviation: Stat Methods Med Res Subsets: MEDLINE

Trimble EL; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Chisti AA; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Craycroft JA; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Duncan K; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Gupta M; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Gutierrez D; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Rosenberg I; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Sharara N; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Sivaram S; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Topazian HM; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Wang JJ; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Williams MJ; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Huang FW; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.; Bhatt AS; National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and University of Hawaii, Honolulu, HI; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Broad Institute of MIT and Harvard, Cambridge, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , National Cancer Institute, Center for Global Heatlh, Bethesda, MD; , Global Oncology, Boston, MA; , National Cancer Institute, Center for Global Health, Bethesda, MD; , Global Oncology, Boston, MA, and Dana-Farber Cancer Institute, Boston, MA; , Global Oncology, Boston, MA, and Stanford University, Stanford, CA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101674751 Publication Model: eCollection Cited Medium: Print ISSN: 2378-9506 (Print) Linking ISSN: 23789506 NLM ISO Abbreviation: J Glob Oncol Subsets: PubMed not MEDLINE

Harris ES; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA. eric.sj.harris@gmail.com; Cao S; Littlefield BA; Craycroft JA; Scholten R; Kaptchuk T; Fu Y; Wang W; Liu Y; Chen H; Zhao Z; Clardy J; Woolf AD; Eisenberg DM

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0330500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1026 (Electronic) Linking ISSN: 00489697 NLM ISO Abbreviation: Sci Total Environ Subsets: MEDLINE

Harris ES; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Ave., Boston, MA 02115, USA. eharris@fas.harvard.edu; Erickson SD; Tolopko AN; Cao S; Craycroft JA; Scholten R; Fu Y; Wang W; Liu Y; Zhao Z; Clardy J; Shamu CE; Eisenberg DM

Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7573 (Electronic) Linking ISSN: 03788741 NLM ISO Abbreviation: J Ethnopharmacol Subsets: MEDLINE